Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome-Reference-Cited by-同舟云学术

Plasma Procalcitonin Is Associated with Obesity, Insulin Resistance, and the Metabolic Syndrome

Published:2010-09 Issue:9 Volume:95 Page:E26-E31
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Abbasi Ali,Corpeleijn Eva,Postmus Douwe,Gansevoort Ron T.,de Jong Paul E.,Gans Rijk O. B.,Struck Joachim,Hillege Hans L.,Stolk Ronald P.,Navis Gerjan,Bakker Stephan J. L.

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study;The Journal of Clinical Endocrinology & Metabolism;2024-04-18

2. Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential;Cardiovascular Diabetology;2023-09-25

3. The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients;Journal of Cancer Research and Clinical Oncology;2022-11-13

4. Procalcitonin mediates vascular dysfunction in obesity;Life Sciences;2022-10

5. Circulating miR‑15b, Annexin A1, procalcitonin and interleukin‑6 levels differentiate children with metabolically unhealthy obesity from those with metabolically healthy obesity: A case‑control study;Experimental and Therapeutic Medicine;2022-04-21